Abstract
EVIDENCE-BASED ANSWER Misoprostol 400 μg, administered vaginally 3 hours before or sublingually 1 hour before first-trimester surgical abortion, is effective for preprocedural cervical dilation but causes more nausea than placebo, especially the sublingual route. Mifepristone may have a greater effect on cervical dilation than misoprostol, but requires dosing 24 hours before the procedure. Vaginal laminaria and vaginal misoprostol are equivalent in terms of need for additional mechanical dilation and average difference in duration of procedure (SOR: C, meta-analysis of RCTs and a noninferiority RCT with disease-oriented outcomes). The Society for Family Planning recommends limiting use of preprocedural cervical ripening medications to patients at increased risk for complications from cervical dilation (SOR: C, expert opinion).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
